Other Applications

Other Advanced Polymer Therapeutics

Exactmer's selective nano‑separation extends beyond oligonucleotides to peptides, ADC linkers and unimolecular PEGs. These applications are in research and development, and we welcome enquiries and collaboration.

One platform

Nanostar Sieving® adds each monomer one at a time to the growing polymer.

That same precision, proven in oligonucleotide synthesis, is what we are now exploring across other sequence defined polymers.

Peptide therapeutic in a vial
2 to 50 amino acids in a typical peptide
Peptides

Peptide Synthesis

Research and development

As demand grows, peptide therapeutic production faces major bottlenecks in its scale of manufacturing, cost effectiveness and sustainable practices. We are developing Nanostar Sieving® processes to help address these needs.

Read the full context

Peptides are molecules typically consisting of 2 to 50 amino acids joined together by peptide bonds, each featuring a unique side chain. Peptides have a long history of cosmetic and therapeutic applications and have recently regained major interest due to new developments in their therapeutic potential.

ShortPeptide fragments through a linear approach
LongerPeptides through an innovative fragment based method
Antibody Drug Conjugate Linkers

Unique PEGabet Technology

Research and development

PEGabets join together Exactmer's bespoke ethylene glycol monomers, each with a functional side group, to generate polymers that combine the gold standard 'stealth' properties of polyethylene glycol with multiple, diverse functionalities and high drug loadings.

Read the full context

Antibody Drug Conjugates (ADCs) have been developed as 'magic bullets' in cancer chemotherapy, combining the specificity of monoclonal antibodies with the potency of chemotherapeutic drugs, connected by a chemical linker. ADCs allow cell killing agents to be delivered directly to the target site, avoiding healthy tissue.

Multiple linker payloads are required to achieve high Drug to Antibody Ratios (DARs), but if the antibody becomes too 'decorated' in this way it can lose affinity for the target site, aggregate in formulation, and hinder its stealth properties. Low DARs prevail, increasing complexity and cost of the medicine.

Useful beyond the field of chemotherapeutic delivery, PEGabets could be used to transport other difficult to deliver therapeutics in the body, including oligos.

The opportunity

Linkers capable of conjugating multiple payloads, with capacity for additional cargo such as cell penetrating agents or combination therapeutics, have the capacity to revolutionise ADCs.

Conventional ADC

Conventional ADC diagram
ChemotherapeuticShort, hydrophobic linker

PEGabet ADC

PEGabet ADC diagram
ChemotherapeuticCell penetrating agentDye (chromophore)Combination therapyPEG‑based linker (hydrophilic, stealthy)

Unimolecular Polyethylene Glycols

PEGylation with Precision

Research and development

Nanostar Sieving® allows each monomer to be added one at a time to the growing polymer, resulting in 'monodisperse' (i.e., unimolecular) PEGs with unparalleled precision and control over the molecular weight (MW).

Read the full context

Polyethylene glycol (PEG) is a water soluble polymer with a wide range of applications. PEGylation, the process of attaching PEG to proteins and drugs, is widely used in the pharmaceutical industry to impart hydrophilicity and 'stealth' properties to therapeutics.

We are experts in PEG chemistry and provide consultations to create bespoke molecules, tailored for our clients' needs. Precise stepwise synthesis eliminates the need for purification by chromatography and maintains uniformity even at high MW, above 2 kDa.

Functional end group chemistries

A range of end group functionalities on unimolecular PEGs, including:

mPEG‑NH₂mPEG‑N₃mPEG‑SHmPEG‑OHPEG‑diol

High Molecular Weights

Unprecedented control over polymer synthesis, even at high MWs above 2 kDa.

Simplified Analysis

Unimolecular PEGs result in less complicated analysis, streamlining development from discovery through to the clinic.

Discrete Activities

Exact PEGs allow for better predictability and consistency of action in biomedicine, where disperse polymers could lead to diverse activity in vivo.

Open to collaboration

Exploring a new polymer therapeutic?

We are open to collaboration on alternative synthesis chemistry and process design, and welcome enquiries on any application of Nanostar Sieving®.